Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
Clinical trial NCT01323920 · COMPLETED
Trial details
- NCT number
- NCT01323920
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-02-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.